Brief: Palisade Bio Q2 EPS USD -0.05
10/08/2026 21:21
BRIEF-Palisade Bio Q2 EPS USD -0.05 Aug 10 (Reuters) - Palisade Bio Q2 operating income USD -11.698 million.
- Q2 operating expenses USD 12.198 million
- Q2 net income USD -10.574 million
Recent news on Palisade Bio
See all newsPalisade Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Palisade Bio Q2 net loss widens on higher R&D costs
Brief: Palisade Bio Q2 EPS USD -0.05
Palisade Bio Inc expected to post a loss of 5 cents a share - Earnings Preview
Brief: Palisade Bio Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing